Better Dose Decisions and a Culture of Statistical Innovation
Om avsnittet
Highlights and timestamps
- 06:09 — Rethinking dose selection with Project Optimus
- 13:11 — Exploring the U-DESPE approach to dose optimization
- 23:07 — How a small team drives statistical innovation
- 29:46 — Moving from everyday challenges to meaningful research
- 32:02 — Creating an environment where innovation can thrive
Links and resources
Saryga
https://saryga.com/
Marie-Karelle Rivière and Anaïs Andrillon — Profiles and Publications
https://saryga.com/about/
Anaïs Andrillon on LinkedIn
https://www.linkedin.com/in/ana%C3%AFs-andrillon-phd-677a89b5/
Marie-Karelle Rivière https://www.linkedin.com/in/marie-karelle-riviere-38342011/
PSI Presentation Slides — U-DESPE
https://www.psiweb.org/docs/default-source/conference/2026-conference-slides/tuesday-16-june/5-epsig_andrillon_anais__micallef_sandrine.pdf?sfvrsn=6b4ca9db_1
PSI Early Phase Special Interest Group
https://www.psiweb.org/sigs-special-interest-groups/early-phase
PSI Special Interest Group Contacts
https://psiweb.org/sigs-special-interest-groups/sigs/sig-lead-contacts
Previous Episode — Project Optimus and What You Need to Know About It
https://theeffectivestatistician.com/project-optimus-and-what-you-need-to-know-about-it/
FDA Project Optimus
https://www.fda.gov/about-fda/oncology-center-excellence/project-optimus
The Effective Statistician - in association with PSI med Alexander Schacht and Benjamin Piske, biometricians, statisticians and leaders in the pharma industry finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.